Literature DB >> 33151348

[Guidelines for sclerotherapy of varicose veins : S2k guideline of the German Society of Phlebology (DGP) in cooperation with the following professional associations: DDG, DGA, DDG, BVP. German Version].

E Rabe1, F X Breu2, I Flessenkämper3, H Gerlach4, S Guggenbichler5, B Kahle6, R Murena7, S Reich-Schupke8, T Schwarz9, M Stücker10, E Valesky11, S Werth12, F Pannier13.   

Abstract

Mesh：

Year:  2021        PMID： 33151348     DOI： 10.1007/s00105-020-04707-y

Source DB:  PubMed          Journal:  Hautarzt        ISSN： 0017-8470            Impact factor:   0.751


× No keyword cloud information.
  151 in total

1.  Guidelines for sclerotherapy of varicose veins (ICD 10: I83.0, I83.1, I83.2, and I83.9).

Authors:  E Rabe; F Pannier-Fischer; H Gerlach; F X Breu; S Guggenbichler; M Zabel
Journal:  Dermatol Surg       Date:  2004-05       Impact factor: 3.398

2.  Ultrasound-guided foam sclerotherapy for treating incompetent great saphenous veins--results of 5 years of analysis and morphologic evolvement study.

Authors:  Chien-Hsun Chen; Cheng-Sheng Chiu; Chih-Hsun Yang
Journal:  Dermatol Surg       Date:  2012-04-27       Impact factor: 3.398

3.  Detergent sclerosants are deactivated and consumed by circulating blood cells.

Authors:  D E Connor; O Cooley-Andrade; W X Goh; D D F Ma; K Parsi
Journal:  Eur J Vasc Endovasc Surg       Date:  2015-02-14       Impact factor: 7.069

4.  Randomized clinical trial comparing endovenous laser ablation, radiofrequency ablation, foam sclerotherapy and surgical stripping for great saphenous varicose veins.

Authors:  L H Rasmussen; M Lawaetz; L Bjoern; B Vennits; A Blemings; B Eklof
Journal:  Br J Surg       Date:  2011-08       Impact factor: 6.939

5.  European guidelines for sclerotherapy in chronic venous disorders.

Authors:  E Rabe; F X Breu; A Cavezzi; P Coleridge Smith; A Frullini; J L Gillet; J J Guex; C Hamel-Desnos; P Kern; B Partsch; A A Ramelet; L Tessari; F Pannier
Journal:  Phlebology       Date:  2013-05-03       Impact factor: 1.740

6.  Randomized clinical trial of ultrasound-guided foam sclerotherapy versus surgery for the incompetent great saphenous vein.

Authors:  N Shadid; R Ceulen; P Nelemans; C Dirksen; J Veraart; G W Schurink; P van Neer; J vd Kley; E de Haan; A Sommer
Journal:  Br J Surg       Date:  2012-05-25       Impact factor: 6.939

7.  Catheter-directed foam sclerotherapy for insufficiency of the great saphenous vein: occlusion rates and patient satisfaction after one year.

Authors:  C Williamsson; P Danielsson; L Smith
Journal:  Phlebology       Date:  2013-05-06       Impact factor: 1.740

8.  Efficacy and safety of sclerotherapy using polidocanol foam: a controlled clinical trial.

Authors:  J Alòs; P Carreño; J A López; B Estadella; M Serra-Prat; J Marinel-Lo
Journal:  Eur J Vasc Endovasc Surg       Date:  2005-10-14       Impact factor: 7.069

9.  Evaluation of the efficacy of polidocanol in the form of foam compared with liquid form in sclerotherapy of the greater saphenous vein: initial results.

Authors:  Claudine Hamel-Desnos; Philippe Desnos; Jan-Christoph Wollmann; Pierre Ouvry; Serge Mako; François-Andre Allaert
Journal:  Dermatol Surg       Date:  2003-12       Impact factor: 3.398

10.  Comparison of 1% and 3% polidocanol foam in ultrasound guided sclerotherapy of the great saphenous vein: a randomised, double-blind trial with 2 year-follow-up. "The 3/1 Study".

Authors:  C Hamel-Desnos; P Ouvry; J-P Benigni; G Boitelle; M Schadeck; P Desnos; F-A Allaert
Journal:  Eur J Vasc Endovasc Surg       Date:  2007-09-20       Impact factor: 7.069
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.